Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity

Shiv K. Singh(Philipps University of Marburg), Nai‐Ming Chen(University of Göttingen), Elisabeth Heßmann(University of Göttingen), Jens T. Siveke(TUM Klinikum), Marlen Lahmann(Philipps University of Marburg), Garima Singh(Philipps University of Marburg), Nadine Voelker(Philipps University of Marburg), Sophia Vogt(Philipps University of Marburg), Iréne Esposito(Helmholtz Zentrum München), Ansgar Schmidt(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg), Thorsten Stiewe(Philipps University of Marburg), Jochen Gaedcke(Nephrologisches Zentrum Goettingen), Marco Mernberger(Philipps University of Marburg), Howard C. Crawford(Mayo Clinic in Florida), William R. Bamlet(Mayo Clinic), Jin‐San Zhang(Mayo Clinic), Xiaokun Li(Wenzhou Medical University), Thomas C. Smyrk(Mayo Clinic in Arizona), Daniel D. Billadeau(Mayo Clinic), Matthias Hebrok(Diabetes Australia), Albrecht Neeße(University of Göttingen), Alexander Köenig(Mayo Clinic), Volker Ellenrieder(University of Göttingen)
The EMBO Journal
January 14, 2015
Cited by 95

Abstract


Related Papers

No related papers found

Powered by citation graph analysis